Caplight Directory>Investors>Access Biotechnology>Access-biotechnology


Access Biotechnology

Access Biotechnology

New York City, New Yorkaccessindustries.com

Overview

Access Biotechnology is the life science investment arm of Access Industries, investing in both private and public biopharma companies developing transformative therapies for conditions with high unmet needs.

Year Founded

2019

Portfolio Companies

18

Investments

CompanyDateStageLead
HemabOct 2025Series CCo-investor
Hemab TherapeuticsOct 2025Series CCo-investor
Treeline BiosciencesSep 2025Series A ExtensionCo-investor
Draig TherapeuticsJun 2025Series ALead
SurrozenMar 2025Private PlacementCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.